IMS
ALNY icon

Index Management Solutions’s Alnylam Pharmaceuticals ALNY Stock Holding History

Index Management Solutions’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$11K Buy
531
+16
+3% +$1.78K 0.01% 509
2015
Q2 		$12K Buy
515
+383
+290% +$45.8K 0.01% 581
2015
Q1 		$14K Buy
+132
New +$13.4K 0.01% 489

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Index Management Solutions's ALNY Position: Q3 2015 in Review

Index Management Solutions increased its Alnylam Pharmaceuticals (ALNY) stake by 3.1% in Q3 2015, buying an estimated $1.78K and bringing the position to 531 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #509.

Index Management Solutions first reported a position in ALNY in Q1 2015 and has held it in 3 quarters since. The position peaked at $14K in Q1 2015. 258 funds tracked by Wall St. Rank hold ALNY as of Q3 2015.

  • Index Management Solutions held 531 shares of Alnylam Pharmaceuticals worth $11K as of Q3 2015.
  • Index Management Solutions bought 16 Alnylam Pharmaceuticals shares in Q3 2015, an estimated $1.78K.
  • Alnylam Pharmaceuticals made up 0.01% of Index Management Solutions's portfolio in Q3 2015, its #509 holding.
  • Index Management Solutions first reported a position in Alnylam Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • Index Management Solutions's Alnylam Pharmaceuticals position peaked at $14K in Q1 2015.
  • 258 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.